-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JFNYZ9UaMw4CBT+OPlu330v3xNXyNxjfL9AmD0JuXVYrwH/4nROy42s58ku4E8qW 3HjFL+hRynfu2KTdOFkwQQ== 0000733337-97-000046.txt : 19970804 0000733337-97-000046.hdr.sgml : 19970804 ACCESSION NUMBER: 0000733337-97-000046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970801 ITEM INFORMATION: Other events FILED AS OF DATE: 19970801 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOPHARMACEUTICS INC CENTRAL INDEX KEY: 0000733337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133186327 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09370 FILM NUMBER: 97650160 BUSINESS ADDRESS: STREET 1: 990 STATION RD CITY: BELLPORT STATE: NY ZIP: 11713 BUSINESS PHONE: 5162865800 MAIL ADDRESS: STREET 1: 990 STATION ROAD CITY: BELLPORT STATE: NY ZIP: 11713 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED GENERICS INC /NV/ DATE OF NAME CHANGE: 19880824 FORMER COMPANY: FORMER CONFORMED NAME: PATIENT MEDICAL SYSTEMS CORP DATE OF NAME CHANGE: 19880615 8-K 1 INFORMATION REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 1997 BIOPHARMACEUTICS, INC. (Exact name of Registrant as specified in its Charter) DELAWARE 1-9370 13-3186327 (State or other (commission File Number) (I.R.S Employer jurisdiction of I.D. Number) incorporation) 990 Station Road Bellport, New York 11713 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (516-286-5800) N/A (Former name or former address, if changed since last report.) ITEM 5. OTHER MATERIAL EVENTS On June 13, 1997 Mr. William Kuger, Vice President of Finance and Chief Accounting Officer resigned from the Company. He was replaced by Vincent H. Pontillo as Controller and Chief Accounting Officer. EXHIBIT INDEX Current Report on Form 8-K of Biopharmaceutics, Inc. Date of Report: August 1, 1997 Exhibit: None SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOPHARMACEUTICS, INC. (Registrant) By: /s/ Edward Fine Edward Fine President, Chief Executive Officer (Signature) Dated: August 1, 1997 -----END PRIVACY-ENHANCED MESSAGE-----